UCSD to Use $20M in NCI Funds to Lead Leukemia Consortium | GenomeWeb

NEW YORK (GenomeWeb News) – The University of California, San Diego said today that it has received a $20 million, five-year grant from the National Cancer Institute to continue leading a research consortium focused on understanding the pathology of chronic lymphocytic leukemia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.